{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-004220","form_type":"8-K","ticker":"RNLXY","cik":"0001811115","company_name":"Renalytix plc","filed_at":"2025-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.977720+00:00","generated_at":"2026-05-28T00:14:04.087974+00:00","sec_items":["7.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Renalytix reverts to foreign private issuer SEC filing status effective Jan 1, 2025","bullets":["Company determined it qualifies as FPI as of Dec 31, 2024; will cease domestic issuer filings.","Effective Jan 1, 2025, Renalytix will file periodic reports using FPI forms.","Company had previously been an FPI but filed as domestic since July 1, 2023.","Change may reduce SEC reporting burden (e.g., no quarterly 10-Q, different GAAP allowed)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-004220","json":"https://secwatch.observer/filing/0001213900-25-004220.json","markdown":"https://secwatch.observer/filing/0001213900-25-004220.md","text":"https://secwatch.observer/filing/0001213900-25-004220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811115/000121390025004220/0001213900-25-004220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811115/000121390025004220/ea0227953-8k_renalytix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T00:14:04.087974+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}